Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate
Arai, T.; Narimiya, S.; Hayakawa, K.; Takaya, T.; Toshima, S.; Araki, M.; Uchida, A.; Yoshimi, N.; Shibuya, C.; Yasuda, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1085-1088
1994
ISSN/ISBN: 0385-0684 PMID: 8002627 Document Number: 435758
Document emailed within 1 workday
Related Documents
Nishi, T.; Funasako, M.; Hata, N.; Andoh, K.; Itoh, Y.; Ono, H.; Itoh, K.; Sato, Y.; Sato, H.; Taniji, M.; Nakai, S.; Ueda, A.; Fujimoto, H.; Ohata, M. 1996: Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(10): 1331-1334Waage, A.; Hammerstrøm, J.; Lødemel, B.; Hoff, J.E.; Langtind, J. 1986: Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(6): 496-497
Hamaoka, R.; Jozaki, K.; Amano, T.; Itoh, H.; Imai, Y.; Nishikawa, M.; Kurokawa, M.; Yonezawa, T.; Chinen, Y. 1995: Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(6): 819-822
Kadowaki, I.; Sasaki, O.; Sasaki, T.; Ishizawa, K.; Kimura, J.; Nomura, J.; Furuyama, K.; Harigae, H.; Shishido, T.; Okuda, M. 1995: Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(1): 145-147
Takami, A.; Nakao, S.; Ontachi, Y.; Yamauchi, H.; Matsuda, T. 1999: Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog International Journal of Hematology 69(1): 24-26
Shalev, Y.; Berrebi, A.; Green, L.; Levin, S.; Frumkin, A.; Hurwitz, N.; Bentwich, Z. 1984: Progressive cutaneous herpes simplex infection in acute myeloblastic leukemia. Successful treatment with interferon and cytarabine Archives of Dermatology 120(7): 922-926
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755
Matsuda, M. 2007: Treatment for myelodysplastic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 1): 516-520
Krafft, T. 1988: Development and treatment of myelodysplastic syndrome Revue Medicale de la Suisse Romande 108(7): 571-572
Hoppe, R.T. 1992: Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease Leukemia 6(Suppl 4): 155-157
Boone, L.I.; Knauer, K.W.; Rapp, S.W.; Stewart, J.F.; Modiano, J.F. 1998: Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dog Journal of the American Veterinary Medical Association 213(7): 999-1001
Elias, L. 1988: The basis for treatment of myelodysplastic syndrome and acute nonlymphoblastic leukemia with biologic agents Leukemia 2(6): 400-402
Fujii, N.; Maeda, Y.; Takenaka, K.; Shinagawa, K.; Imai, T.; Kozuka, T.; Ikeda, K.; Sunami, K.; Hiramatsu, Y.; Ishimaru, F.; Niiya, K.; Harada, M. 2000: Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide: report of 2 cases International Journal of Hematology 72(4): 499-503
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097
Jäger, G.; Höfler, G.; Linkesch, W.; Neumeister, P. 2004: Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature Haematologica 89(4): Ecr01
Borberg, H.; Kindler, J.; Mahieu, B.; Sladecek, I.; Tschöpe, W.; Sieberth, H.G.; Gross, R. 1978: Treatment of the Goodpasture syndrome. Successful combination of plasma exchange and treatment with immunosuppressive agents Die Medizinische Welt 29(13): 545-547
Kamesaki, T.; Akifuji, Y.; Mori, M.; Ueki, J.; Nakamoto, S.; Kajii, E.; Ikemoto, S. 1993: A patient with Tn syndrome associated with myelodysplastic syndrome showed abnormal glycophorin B International Journal of Hematology 58(1-2): 113-118
Teramoto, S.; Katsumura, T.; Ono, K.; Senoo, Y.; Hayashi, I. 1973: Successful surgical treatment in Marfan's syndrome Kyobu Geka. Japanese Journal of Thoracic Surgery 26(3): 180-184
Coll-Vinent, B.; Pedrol, E.; Casademont, J.; Cid, M.C.; Grau, J.M. 1994: Sweet's syndrome associated with mesenteric lipodystrophy and a myelodysplastic syndrome Presse Medicale 23(25): 1180
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005